SOLENTIS Trademark

Trademark Overview

On Thursday, November 1, 2018, a trademark application was filed for SOLENTIS with the United States Patent and Trademark Office. The USPTO has given the SOLENTIS trademark a serial number of 79247159. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, March 10, 2020. This trademark is owned by Bioeq AG. The SOLENTIS trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for treatment of age-related macular degeneration
solentis

General Information

Serial Number79247159
Word MarkSOLENTIS
Filing DateThursday, November 1, 2018
Status601 - ABANDONED - EXPRESS
Status DateTuesday, March 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicines for treatment of age-related macular degeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCH
Party NameBioeq AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressZug CH-6300
CH

Trademark Events

Event DateEvent Description
Monday, July 12, 2021CHANGE OF OWNER RECEIVED FROM IB
Sunday, March 28, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 10, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 10, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 6, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 6, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, March 10, 2020ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Tuesday, March 10, 2020ABANDONMENT - EXPRESS MAILED
Monday, March 9, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, March 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 13, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, September 13, 2019FINAL REFUSAL E-MAILED
Friday, September 13, 2019FINAL REFUSAL WRITTEN
Saturday, August 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 16, 2019REFUSAL PROCESSED BY IB
Saturday, February 23, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 23, 2019REFUSAL PROCESSED BY MPU
Friday, February 15, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 14, 2019NON-FINAL ACTION WRITTEN
Thursday, February 7, 2019ASSIGNED TO EXAMINER
Tuesday, December 18, 2018APPLICATION FILING RECEIPT MAILED
Friday, December 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 6, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

solentis degeneration macular related treatment medicines